| Title: |
Sputum Inflammatory Patterns Are Associated With Distinct Clinical Characteristics in Patients with Occupational Asthma Independently of the Causal Agent |
| Authors: |
Migueres, N; Vandenplas, O; Walusiak-Skorupa, J; Wiszniewska, M; Munoz, X; Romero-Mesones, C; Suojalehto, H; Lindström, I; van Kampen, V; Merget, R; Mason, P; Maestrelli, P; Sastre, J; Quirce, S; Rifflart, C; Godet, J; de Blay, F |
| Contributors: |
Migueres, N; Vandenplas, O; Walusiak-Skorupa, J; Wiszniewska, M; Munoz, X; Romero-Mesones, C; Suojalehto, H; Lindström, I; van Kampen, V; Merget, R; Mason, P; Maestrelli, P; Sastre, J; Quirce, S; Rifflart, C; Godet, J; de Blay, F |
| Publication Year: |
2024 |
| Collection: |
Padua Research Archive (IRIS - Università degli Studi di Padova) |
| Subject Terms: |
Eosinophil; Induced sputum; Neutrophil; Occupational asthma; Phenotype |
| Description: |
Background and objectives: Clinical heterogeneity in sensitizer-induced occupational asthma (OA) and its relationship to airway inflammatory profiles remain poorly elucidated. To further characterize the interactions between induced sputum inflammatory patterns, asthma-related outcomes and the high- or low-molecular-weight category of causal agents in a large cohort of subjects with OA. Methods: This multicenter, retrospective, cross-sectional study was conducted among 296 subjects with OA ascertained by a positive specific inhalation challenge who completed induced sputum assessment before and 24 hours after challenge exposure. Results: Multivariate logistic regression analysis revealed that sputum eosinophilia ≥3% was significantly associated with a high dose of inhaled corticosteroid (odds ratio [95% confidence interval], 1.31 [1.11-1.55] for each 250-μg increment in daily dose), short-acting b2-agonist use less than once a day (3.54 [1.82-7.00]), and the level of baseline nonspecific bronchial hyperresponsiveness (mild: 2.48 [1.21-5.08]); moderate/severe: 3.40 [1.44-8.29]). Sputum neutrophilia ≥76% was associated with age (1.06 [1.01-1.11]), male gender (3.34 [1.29-9.99]), absence of corticosteroid use (5.47 [2.09-15.16]), short-acting b2-agonist use once or more a day (4.09 [1.71-10.01]), ≥2 severe exacerbations during the last 12 months at work (4.22 [1.14-14.99]), and isolated early reactions during the SIC (4.45 [1.85-11.59]). Conclusions: The findings indicate that sputum inflammatory patterns in subjects with OA are associated with distinct phenotypic characteristics and further highlight the differential effects of neutrophils and eosinophils on asthma-related outcomes. These associations between inflammatory patterns and clinical characteristics share broad similarities with what has been reported in nonoccupational asthma and are not related to the type of causal agent. |
| Document Type: |
article in journal/newspaper |
| File Description: |
STAMPA |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/36377541; info:eu-repo/semantics/altIdentifier/wos/WOS:001208961300001; volume:34; issue:2; firstpage:0; journal:JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY; https://hdl.handle.net/11577/3543501; https://www.jiaci.org/revistas/doi10.18176_jiaci.0868.pdf |
| DOI: |
10.18176/jiaci.0868 |
| Availability: |
https://hdl.handle.net/11577/3543501; https://doi.org/10.18176/jiaci.0868; https://www.jiaci.org/revistas/doi10.18176_jiaci.0868.pdf |
| Rights: |
info:eu-repo/semantics/openAccess ; license:Accesso libero ; license uri:publisher |
| Accession Number: |
edsbas.C527D35F |
| Database: |
BASE |